Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation-Reference-Cited by-同舟云学术

Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation

Published:2003-09 Issue:3 Volume:39 Page:389-396
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Forns Xavier,Garcı́a-Retortillo Montserrat,Serrano Trinidad,Feliu Anna,Suarez Francisco,de la Mata Manuel,Garcı́a-Valdecasas Juan Carlos,Navasa Miquel,Rimola Antoni,Rodés Juan

Publisher

Elsevier BV

Subject

Hepatology

Reference21 articles.

1. Hepatitis C and liver transplantation;Berenguer;J Hepatol,2001

3. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes;Prieto;Hepatology,1999

4. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft1;Sanchez-Fueyo;Transplantation,2002

5. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients;Berenguer;Hepatology,2002

Cited by 264 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine Learning Model Validated to Predict Outcomes of Liver Transplantation Recipients with Hepatitis C: The Romanian National Transplant Agency Cohort Experience;Sensors;2023-02-14

2. Outcome of hepatitis C–related liver transplantation in direct-acting antiviral era;Indian Journal of Gastroenterology;2020-11-24

3. Biological Principles and Clinical Issues Underlying Liver Transplantation for Viral‐Induced End‐Stage Liver Disease in the Era of Highly Effective Direct‐Acting Antiviral Agents;The Liver;2020-01-24

4. The road map toward an hepatitis C virus-free transplant population;American Journal of Transplantation;2018-07-21

5. Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy;BMC Cancer;2018-03-06